Amyloid-beta 42/40
7 papers2 findings
- Humans7
Effects
1Cognitive function composite score
no changein humans1
1 study
Cognitive function composite score
no changein humans1
Amyloid-beta 42/40 has no effect on cognitive function composite score in humans.
“No significant associations were found between Aβ42/40 and changes in the other five cognitive domains or the composite score.”
Humans5 to 7 yearsn = 250
AAIC 2025 abstract25 Dec 2025
Associations
1Cognitive processing speed
downin humans1
1 study
Cognitive processing speed
downin humans1
Amyloid-beta 42/40 is associated with cognitive processing speed in humans (β 0.123; 95% CI [0.018 – 1.042]).
“Lower levels of Aβ42/40 were associated with a steeper decline in processing speed over the follow‐up period (β 0.123; 95% CI [0.018 – 1.042]).”
Humanscerebrospinal fluid5 to 7 yearsn = 250
AAIC 2025 abstract25 Dec 2025
Latest
7 in 12 monthsAAIC 2025 Abstract
Associations of Estradiol and APOE4 Genotype with Hippocampal Connectivity during Verbal Encoding in Postmenopausal Women
Cohort study of 172 peopleMechanisms
GSA 2025 Abstract
Change in Alzheimer’s Disease Blood-Based Biomarkers and Associations With Cortical Thickness
Cohort study of 1,515 peopleCortical thickness
AAIC 2025 Abstract
Prediction of future tau accumulation and cognitive decline in Down Syndrome using plasma biomarkers
Cohort study of 258 peopleDown syndrome
Alzheimer's & Dementia
Data-driven neuropsychological phenotypes in the Baltimore Longitudinal Study of Aging
Cohort study of 1,192 peopleBiomarkers
Journal of Alzheimer's Disease
Cross-sectional associations between lifecourse dementia risk factors, plasma neurodegenerative biomarkers, and cognition in older adults in India
Cross-sectional study of 1,625 peopleDementia
GSA 2024 Abstract
SEABIRD: RECRUITING A DIVERSE COMMUNITY-BASED POPULATION FOR AN ALZHEIMER’S BLOOD TEST STUDY
Cohort study of 1,122 peopleAlzheimer's disease
The Journal of Prevention of Alzheimer's Disease
Prospective Associations between Plasma Amyloid-Beta 42/40 and Frailty in Community-Dwelling Older Adults
Cohort study of 477 peopleAmyloid-beta